[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.236.145.124. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 416
Citations 0
Comment & Response
June 14, 2016

Assessing Evidence for Physician Orders for Life-Sustaining Treatment Programs—Reply

Author Affiliations
  • 1Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • 2Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania, Philadelphia
  • 3Fostering Improvement in End-of-Life Decision Science Program, University of Pennsylvania, Philadelphia
 

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2016;315(22):2472. doi:10.1001/jama.2016.4039

In Reply Dr Tolle and colleagues contend that the current evidence available regarding POLST justifies nationwide implementation of the program. Although an important start in understanding how POLST is currently being used, all available evidence stems from retrospective observational studies that are prone to confounding. There have been no published studies with suitable control groups, let alone studies using experimental designs capable of truly determining whether POLST completion affects patient outcomes. Additionally, the majority of research on POLST has been performed in Oregon, a state with unique demographic and cultural factors that may limit the generalizability of the findings.

×